China's phase 2 trial finds COVID-19 vaccine safe, inducing immune response -- The Lancet


来源: 粤港澳头条   时间:2020-07-22 08:22:09





File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)

File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)

 

A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.

 

  版权及免责声明:凡本网所属版权作品,转载时须获得授权并注明来源“粤港澳头条”,违者本网将保留追究其相关法律责任的权力。凡转载文章,不代表本网观点和立场。版权事宜请联系:13804373525。



版权所有:粤港澳头条吉ICP备19000464号-1